Management of Mastitis Using Trans-Disciplinarily Validated Ethno-Veterinary Practices
Mastitis is an inflammation of the mammary gland generally associated with intra-mammary infection (IMI) with certain microbes. Though common mastitis-causing bacteria are the main cause of mastitis, other organisms like viruses, fungi, yeast, certain microscopic algae (Prototheca spp.) and even phy...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2023
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/88341 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Mastitis is an inflammation of the mammary gland generally associated with intra-mammary infection (IMI) with certain microbes. Though common mastitis-causing bacteria are the main cause of mastitis, other organisms like viruses, fungi, yeast, certain microscopic algae (Prototheca spp.) and even physical injury might cause mastitis. The University of Transdisciplinary Health Science and Technology (TDU) conducted a participatory documentation of ethno-veterinary practice (EVP) and transdisciplinary assessment involving Siddha-Ayurveda, and Western pharmacology and established the safety and efficacy of EVP. In-vitro antimicrobial activity, clinical and molecular docking studies indicated anti-inflammatory and anti-microbial properties of EVP formulation for mastitis. The microbiome of milk from the cows with clinical mastitis indicates that after 6 days of treatment with herbal formulations, the average abundance of microbes causing mastitis was reduced substantially. Microbiome abundance in the milk of EVP-treated cows is almost similar to that of the control after 6 days. However, microbiome abundance in the milk from the antibiotic-treated cow varied substantially from the milk of the control. The clinical intervention with EVM preparations on 181,252 cows in a multicentric field study for a period of 5 years on the efficacy of EVP for subclinical, clinical and chronic mastitis with multifactorial aetiology resulted in a clinical recovery in 84.9% of cases. |
|---|---|
| ISBN: | 978-1-83769-285-9 |
| DOI: | 10.5772/intechopen.112976 |